Ready For the Recreational Cannabis Market

Cannabis Company MediPharm Labs is focused on the purity and quality of their cannabinoids.

A leader in cannabis extraction and purification, MediPharm Labs has invested in an expert team, state-of-the-art technology, advanced methodologies and a purpose-built facility to deliver pure, safe and precisely-dosed cannabis concentrates and advanced derivative products.

Founded in 2015, MediPharm Labs Inc. is a pioneer in the cannabis industry and has the distinction of being the first company in Canada to become a licensed producer for cannabis oil production under the Access to Cannabis for Medical Purposes Regulations (ACMPR) without first receiving a cannabis cultivation license. This expert focus on cannabis concentrates from our cGMP (current Good Manufacturing Practices) and ISO standard clean rooms and critical environments laboratory, allows MediPharm to work with its established, Health Canada-approved cultivation partners to produce pharmaceutical-grade cannabis oil with a competitive advantage. MediPharm is research-driven and focused on downstream secondary extraction methodology, distillation, and cannabinoid isolation and purification.

MediPharm’s state-of-the-art facility is in compliance with European current Good Manufacturing Practices (cGMP) requirements and designed to ISO standard cleanrooms and critical environments. The standard of design and construction are currently the most innovative and technically advanced in the Canadian cannabis industry.

These pharma-grade critical environments combined with our discipline and proprietary methodologies result in repeatability in manufacturing, precision dosing, and purity assurance. These foundations of our organization ultimately deliver trusted, safe products for patients or end consumers.

For more information on MediPharm Labs (LABS.TSX.V) please fill out the form below.

Request Investor Kit